Using a cell line-based prostate cancer xenograft model, the authors demonstrated that VTP induces the recruitment of myeloid-derived suppressor cells (MDSCs) to treated tumors as well as their expression of colony-stimulating factor 1 receptor (CSF1R), which is required for myeloid differentiation, proliferation, and tumor migration. This evidence concerns the gene CSF1R and prostate carcinoma.